1. 213 Use of A novel peptide ligand targeting multiple immune checkpoints: a novel approach to immunotherapy against central nervous system tumors. (10th December 2020) Authors: Moertel, Christopher; Xiong, Zhengming; Olin, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 213 Use of A novel peptide ligand targeting multiple immune checkpoints: a novel approach to immunotherapy against central nervous system tumors. (9th November 2020) Authors: Moertel, Christopher; Xiong, Zhengming; Olin, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autonomic Cross-Innervation in Patients With Neurofibromatosis Type 2: Frey Syndrome and Unilateral Epiphora With Rhinorrhea. (6th August 2019) Authors: Evans, Erica; Nascene, David; Sommer, Katherine; Moertel, Christopher Journal: Child neurology open Issue: Volume 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and Toxicities. (March 2019) Authors: Sverak, Pavlina; Adams, Meredith E.; Haines, Stephen J.; Levine, Samuel C.; Nascene, David; Sommer, Katherine; Dusenbery, Kathryn; Huang, Tina C.; Moertel, Christopher Journal: Otolaryngology--head and neck surgery Issue: Volume 160:Number 3(2019) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient‐Reported Outcomes and Toxicities. (30th October 2018) Authors: Sverak, Pavlina; Adams, Meredith E.; Haines, Stephen J.; Levine, Samuel C.; Nascene, David; Sommer, Katherine; Dusenbery, Kathryn; Huang, Tina C.; Moertel, Christopher Journal: Otolaryngology--head and neck surgery Issue: Volume 160:Number 3(2019) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BIOM-49. A PILOT STUDY OF CEREBROSPINAL FLUID EXOSOMAL SMALL RNA-SEQUENCING IN PEDIATRIC MEDULLOBLASTOMA PATIENTS ON THE NEXT CONSORTIUM "HEAD START" 4 PROTOCOL. (14th November 2022) Authors: Bell, Erica; Webb, Amy; Stanek, Joseph; Blue, Megan; Patel, Parth; Thomas, Diana; Pierson, Christopher; Mladkova, Nikol; Fleming, Jessica; Miller, Katherine; Grischow, Olivia; Liszkay, Thomas; Olshefski, Randall; Chi, Susan; Comito, Melanie; Friedman, Gregory; Bendel, Anne; Coven, Scott; Hastings... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CD200AR-L: mechanism of action and preclinical and clinical insights for treating high-grade brain tumors. (2nd September 2022) Authors: Moertel, Christopher; Martinez-Puerta, Francisco; Pluhar, Grace G. Elizabeth; Castro, Maria Graciela; Olin, Michael Journal: Expert opinion on investigational drugs Issue: Volume 31:Number 9(2022) Page Start: 875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study. (November 2021) Authors: Khan, Sara; Solano-Paez, Palma; Suwal, Tannu; Lu, Mei; Al-Karmi, Salma; Ho, Ben; Mumal, Iqra; Shago, Mary; Hoffman, Lindsey M; Dodgshun, Andrew; Nobusawa, Sumihito; Tabori, Uri; Bartels, Ute; Ziegler, David S; Hansford, Jordan R; Ramaswamy, Vijay; Hawkins, Cynthia; Dufour, Christelle; André, Nico... Journal: Lancet Issue: Volume 5:Number 11(2021) Page Start: 800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTIM-11. PHASE 2 STUDY OF SL-701, A NOVEL IMMUNOTHERAPY, IN ADULTS WITH RECURRENT GBM: A HIGH PARAMETER FLOW CYTOMETRY ANALYSIS OF CD8+ T CELLS AND POTENTIAL IMPLICATIONS FOR PATIENT ENRICHMENT STRATEGIES. (12th November 2021) Authors: Peereboom, David; Lindsay, Ross; Badruddoja, Michael; Nabors, L Burt; Kumthekar, Priya; Lieberman, Frank; Tran, David; Phuphanich, Surasak; Schiff, David; Sherman, Jonathan; Butowski, Nicholas; Dunbar, Erin; Fink, Karen; Iwamoto, Fabio; Moertel, Christopher; Schulder, Michael; Walbert, Tobias; Ha... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CTIM-15. FIRST-IN-HUMAN PHASE 1 STUDY OF CD200 ACTIVATION RECEPTOR-LIGAND (CD200AR-L) AND ALLOGENEIC TUMOR LYSATE VACCINE IMMUNOTHERAPY FOR RECURRENT GLIOBLASTOMA: INITIAL RESULTS FROM AN ONGOING CLINICAL TRIAL. (12th November 2021) Authors: Neil, Elizabeth; Eaton, Anne; Lunn, Shannon; Nelson, Kristen; Greengard, Emily; Moertel, Christopher; Olin, Michael Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗